Methyl gallate (monomethyl ester of gallic acid)

Methyl gallate is the monomethyl ester of gallic acid, a phenolic acid found naturally in plants such as Rhus chinensis and Paeonia lactiflora. It exerts antioxidant activity primarily by donating hydrogen atoms to neutralize free radicals via its trihydroxybenzene ring structure, and shows early-stage evidence for anti-inflammatory and anti-tumor properties.

Origin & History

Methyl gallate is the methyl ester of gallic acid (C₈H₈O₅), a naturally occurring phenolic compound found in various plants including Terminalia myriocarpa, Bergenia ciliata, Geranium niveum, and Paeonia anomala fruit, as well as in wine. It is produced naturally in these plant sources and can be synthesized as a crystalline solid for research purposes.

Historical & Cultural Context

The research dossier does not contain any information about traditional or historical medicinal use of methyl gallate. While it occurs naturally in several plants and wine, traditional applications are not documented in the provided sources.

Health Benefits

• Antioxidant properties (evidence quality: preliminary - based on chemical database classifications only)
• Anti-tumor activity (evidence quality: preliminary - no clinical trials provided)
• Anti-inflammatory effects (evidence quality: preliminary - no human studies available)
• Note: No clinical evidence was provided in the research dossier
• All benefits are based on chemical property classifications rather than human trials

How It Works

Methyl gallate scavenges reactive oxygen species (ROS) by donating electrons through its trihydroxyphenyl (pyrogallol) moiety, inhibiting lipid peroxidation chain reactions. In inflammation models, it suppresses NF-κB signaling, reducing downstream expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, while also inhibiting COX-2 enzyme activity. Anti-tumor activity in cell studies has been linked to induction of mitochondria-mediated apoptosis via caspase-3 and caspase-9 activation and downregulation of Bcl-2 proteins.

Scientific Research

No clinical trials, randomized controlled trials, or meta-analyses were found in the provided research dossier. The available information comes exclusively from chemical databases and safety data sheets rather than peer-reviewed clinical literature.

Clinical Summary

No published human clinical trials specifically evaluating methyl gallate as an isolated compound exist as of the current literature. Evidence is derived exclusively from in vitro cell studies and rodent models, where oral administration in mice at doses of approximately 20–50 mg/kg has demonstrated anti-inflammatory and hepatoprotective effects. Antioxidant potency has been characterized in chemical assays (DPPH, ABTS), where methyl gallate shows IC50 values comparable to or slightly lower than gallic acid itself. The overall evidence quality remains preliminary, and no clinically validated dosing, efficacy endpoints, or safety data in humans have been established.

Nutritional Profile

Methyl gallate (methyl 3,4,5-trihydroxybenzoate; C₈H₈O₅; MW 184.15 g/mol) is a phenolic compound, not a food or nutrient source per se. It is the monomethyl ester of gallic acid and is found naturally in trace amounts in certain plants, fruits, and teas. Key bioactive characteristics: • Single defined compound — a polyphenolic ester with three free hydroxyl groups on the aromatic ring responsible for its radical-scavenging (antioxidant) capacity. • Typical natural occurrence: found at low concentrations (often <0.01–0.1% dry weight) in sources such as Terminalia chebula fruit, Galla chinensis (Chinese gallnut), certain Rhus species, some wines, and various tea preparations. • No macronutrient contribution (negligible protein, fat, carbohydrate, or caloric value at bioactive doses). • No meaningful vitamin or mineral content. • Bioactive concentration when isolated: typically studied in vitro at 10–200 µM; in vivo animal studies use doses roughly 10–50 mg/kg body weight. • Key functional groups: three phenolic –OH groups (positions 3, 4, 5) and one methyl ester group; the phenolic hydroxyls drive DPPH/ABTS radical scavenging with IC₅₀ values reported in the range of 2–10 µg/mL in standard antioxidant assays, comparable to or slightly lower than gallic acid. • Bioavailability notes: Oral bioavailability is expected to be low-to-moderate, analogous to gallic acid; subject to extensive Phase II metabolism (glucuronidation, sulfation, methylation) in the gut wall and liver. The methyl ester group may undergo hydrolysis by esterases in the GI tract, partially converting methyl gallate back to gallic acid before absorption. Plasma half-life is estimated to be short (minutes to low hours), consistent with small polyphenolics. No human pharmacokinetic studies are currently published. • Related metabolites: gallic acid (hydrolysis product), 4-O-methylgallic acid (possible Phase II metabolite). • Solubility: moderately soluble in water (~10–20 mg/mL at 25 °C), freely soluble in methanol and ethanol. • LogP ≈ 0.8–1.0, indicating moderate lipophilicity. • No established Recommended Daily Intake, Tolerable Upper Intake Level, or nutritional reference value exists for this compound.

Preparation & Dosage

No clinically studied dosage ranges are available from the research provided. The only dosage-related information is laboratory solubility data (0.33 mg/ml in DMF:PBS solution). Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Gallic acid, vitamin C, quercetin, resveratrol, green tea polyphenols

Safety & Interactions

No human safety trials for isolated methyl gallate have been conducted, making comprehensive risk profiling impossible at this time. Animal studies have not reported acute toxicity at moderate doses, but high-dose or chronic exposure data in humans are absent. Because methyl gallate may inhibit platelet aggregation and possess mild anticoagulant-like activity in vitro, theoretical interactions with anticoagulant drugs such as warfarin or antiplatelet agents like aspirin warrant caution. Pregnant or breastfeeding individuals should avoid supplementation due to a complete lack of reproductive safety data.